For the Inventor, By the Inventor

Enter assignee name

Copiague, NY, United States of America

American Biogenetic Sciences, Inc.

USPTO Granted Patents = 23

% Expired Patents = 4.3

CIPO Patents = 4

Forward Citations = 298

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Paul E Gargan (12 out of 13 patents)

Julian R Pleasants (9 out of 9 patents)

Victoria A Ploplis (9 out of 9 patents)

4. Heinz Nau (4 out of 7 patents)

5. Andrei G Zhiglinsky (4 out of 4 patents)

6. Alexander M Izmailov (4 out of 4 patents)

7. Emer Leahy (2 out of 7 patents)

8. Alan O'Connell (2 out of 2 patents)

9. Ciaran M Regan (2 out of 6 patents)

10. Elliot D Rosen (2 out of 3 patents)

11. Jack T Stapleton (1 out of 10 patents)

12. John D Scheu (1 out of 1 patent)

13. Malcolm J Fraser (1 out of 2 patents)

14. Victoria A Ploplis (1 out of 2 patents)

15. Patricia L Winokur (1 out of 1 patent)

23 patents: Sort by Forward Citations

1. 6458840 - Use of valproic acid analog for the treatment and prevention of migraine and affective illness (2002-10-01),

2. 6294173 - Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein (2001-09-25),

3. 6274624 - Antiproliferative and neurotrophic molecules (2001-08-14),

4. 6268396 - Use of valproic acid analog for the treatment and prevention of migraine and affective illness (2001-07-31),

5. 6187593 - Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein (2001-02-13),

6. 6080384 - Methods for radionuclide-labeling of biomolecules and kits utilizing the (2000-06-27),

7. 5871737 - Methods for treating a fibrin encapsulated tumor using a fibrin specific (1999-02-16),

8. 5843690 - Immunoassay and kit for in vitro detection of soluble DesAABB fibrin (1998-12-01),

9. 5723126 - Methods and compositions for therapeutic uses of a fibrin-specific (1998-03-03),

10. 5721122 - Method comprising immunization of antigen-free mice (1998-02-24),

11. 5672746 - Antiproliferative and neurotrophic molecules (1997-09-30),

12. 5487892 - Method for treating thrombotic disease using a fibrin specific (1996-01-30),

13. 5453359 - Immunoassay and kit for in vitro detection of soluble DesAABB fibrin (1995-09-26),

14. 5428635 - Multi-wavelength tunable laser (1995-06-27),

15. 5418805 - Device for pumping the active medium of a white light laser (1995-05-23),

American Biogenetic Sciences, Inc. is a biotechnology company specializing in the development and commercialization of innovative therapeutics for various diseases. With a focus on molecular biology and genetic engineering, the company aims to revolutionize healthcare by findng breakthrough solutions for complex medical challenges. Visit their website for more information about their products, research, and partnerships.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

23 Patents

#2 in Copiague, NY

#864 in New York

#14,394 in US

#27,598 in the World

Copiague, NY, United States of America

American Biogenetic Sciences, Inc.

Forward Citations = 298

17 inventors:

Paul E Gargan (12 out of 13 patents)

Julian R Pleasants (9 out of 9 patents)

Victoria A Ploplis (9 out of 9 patents)

4. Heinz Nau (4 out of 7 patents)

5. Andrei G Zhiglinsky (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…